Arnaud Roth

8.7k total citations · 2 hit papers
115 papers, 5.1k citations indexed

About

Arnaud Roth is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Arnaud Roth has authored 115 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Oncology, 54 papers in Pulmonary and Respiratory Medicine and 47 papers in Surgery. Recurrent topics in Arnaud Roth's work include Colorectal Cancer Treatments and Studies (51 papers), Gastric Cancer Management and Outcomes (41 papers) and Colorectal and Anal Carcinomas (25 papers). Arnaud Roth is often cited by papers focused on Colorectal Cancer Treatments and Studies (51 papers), Gastric Cancer Management and Outcomes (41 papers) and Colorectal and Anal Carcinomas (25 papers). Arnaud Roth collaborates with scholars based in Switzerland, Belgium and France. Arnaud Roth's co-authors include Sabine Tejpar, Fred T. Bosman, Mauro Delorenzi, Eric Van Cutsem, Pu Yan, G. Bodoky, Bernard Nordlinger, Roberto Labianca, Daniel Dietrich and Laura A. Cisar and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Arnaud Roth

107 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial

2009 893 citations Arnaud Roth, Sabine Tejpar et al. Journal of Clinical Oncology profile →
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer

2014 414 citations Arnaud Roth et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arnaud Roth Switzerland	34	3.4k	1.8k	1.4k	1.3k	860	115	5.1k
Jae Kyung Roh South Korea	30	4.2k 1.2×	1.8k 1.0×	1.3k 0.9×	1.2k 0.9×	1.1k 1.3×	156	5.9k
Piercarlo Saletti Switzerland	29	4.3k 1.2×	2.1k 1.1×	1.6k 1.1×	941 0.7×	1.0k 1.2×	74	5.5k
Filippo Pietrantonio Italy	37	2.9k 0.9×	1.5k 0.8×	1.2k 0.8×	1.1k 0.9×	1.1k 1.3×	298	5.0k
Astrid Lièvre France	29	4.4k 1.3×	2.2k 1.2×	1.7k 1.2×	1.3k 1.0×	1.4k 1.6×	175	6.2k
Ilhan Celik Germany	15	2.8k 0.8×	1.6k 0.9×	911 0.6×	682 0.5×	749 0.9×	31	3.9k
Michelle R. Mahoney United States	32	3.4k 1.0×	1.7k 0.9×	1.3k 0.9×	1.2k 0.9×	757 0.9×	71	4.8k
Vincenzo Catalano Italy	40	3.1k 0.9×	1.6k 0.9×	900 0.6×	1.2k 0.9×	1.4k 1.6×	124	5.1k
Dominik Paul Modest Germany	36	3.5k 1.0×	1.6k 0.9×	1.1k 0.8×	833 0.7×	620 0.7×	206	4.4k
J. Załuski Poland	13	3.7k 1.1×	1.7k 0.9×	929 0.6×	816 0.6×	574 0.7×	23	4.5k
Allen Lee Cohn United States	38	4.7k 1.4×	2.4k 1.3×	1.0k 0.7×	875 0.7×	1.5k 1.8×	159	6.9k

Countries citing papers authored by Arnaud Roth

Since Specialization

Citations

This map shows the geographic impact of Arnaud Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Roth more than expected).

Fields of papers citing papers by Arnaud Roth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Roth. The network helps show where Arnaud Roth may publish in the future.

Co-authorship network of co-authors of Arnaud Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Roth. A scholar is included among the top collaborators of Arnaud Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Roth. Arnaud Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moehler, Markus, Arno Schad, Annett Maderer, et al.. (2018). Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071). Cancer Chemotherapy and Pharmacology. 82(4). 733–739. 13 indexed citations

Kountouri, Melpomeni, Arnaud Roth, Jean‐Louis Frossard, et al.. (2018). Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review. Critical Reviews in Oncology/Hematology. 124. 61–65. 20 indexed citations

Cacheux, Wulfran, Thibaud Koessler, Giacomo Puppa, et al.. (2017). Early closure of fistula using neo-adjuvant intra-arterial chemotherapy in locally advanced anal cancer. Digestive and Liver Disease. 49(11). 1262–1266. 2 indexed citations

Moos, Roger von, Dieter Koeberle, Stefanie Hayoz, et al.. (2017). Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS -mutated rectal cancer: A phase I/II trial (SAKK 41/08). European Journal of Cancer. 89. 82–89. 20 indexed citations

Barras, David, Edoardo Missiaglia, Pratyaksha Wirapati, et al.. (2016). BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression. Clinical Cancer Research. 23(1). 104–115. 161 indexed citations

Yan, Pu, Dirk Klingbiel, Zenia Saridaki, et al.. (2016). Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer. Clinical Cancer Research. 22(12). 3037–3047. 62 indexed citations

Koessler, Thibaud, Philippe Bichard, Vincent Lépilliez, et al.. (2016). Epidémiologie, prise en charge et suivi des polypes colorectaux. Revue Médicale Suisse. 12(519). 982–988.

Nygård, Sune Boris, Ben Vainer, Fred T. Bosman, et al.. (2015). DNA Topoisomerase I Gene Copy Number and mRNA Expression Assessed as Predictive Biomarkers for Adjuvant Irinotecan in Stage II/III Colon Cancer. Clinical Cancer Research. 22(7). 1621–1631. 12 indexed citations

Lacombe, Denis, Sabine Tejpar, Roberto Salgado, et al.. (2014). European perspective for effective cancer drug development. Nature Reviews Clinical Oncology. 11(8). 492–498. 26 indexed citations

10.

Popovici, Vlad, Eva Budínská, Fred T. Bosman, et al.. (2013). Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer. BMC Cancer. 13(1). 439–439. 31 indexed citations

11.

Popovici, Vlad, Eva Budínská, Sabine Tejpar, et al.. (2012). Identification of a Poor-Prognosis BRAF-Mutant Like Populationof Patients With Colon Cancer. Journal of Clinical Oncology,30(12):12BB-1295, 2012. Journal of Clinical Oncology. 1 indexed citations

12.

Terraz, Sylvain, Thierry Berney, Thai Nguyen‐Tang, et al.. (2012). Common bile duct adenocarcinoma in a patient with situs inversus totalis: report of a rare case. BMC Research Notes. 5(1). 681–681. 17 indexed citations

13.

Budínská, Eva, Vlad Popovici, Katarzyna Sikora, et al.. (2012). Identification and validation of gene expression subtypes in a large set of colorectal cancer samples.. Journal of Clinical Oncology. 30(15_suppl). 3511–3511.

14.

Zilli, Thomas, Ulrike Schick, Mahmut Özsahin, et al.. (2011). Node-negative T1–T2 anal cancer: Radiotherapy alone or concomitant chemoradiotherapy?. Radiotherapy and Oncology. 102(1). 62–67. 29 indexed citations

15.

Biffi, Roberto, Nicola Fazio, Fabrizio Luca, et al.. (2010). Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer.. PubMed. 16(7). 868–74. 68 indexed citations

16.

Cutsem, Eric Van, Cornelius Van de Velde, Arnaud Roth, et al.. (2008). Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) - gastrointestinal cancer group. European Journal of Cancer. 44(2). 182–194. 76 indexed citations

17.

Roth, Arnaud. (2002). European experience of docetaxel and cisplatin in advanced gastric cancer. Gastric Cancer. 5(S1). 27–29.

18.

Allal, Abdelkarim S., Bernadette Mermillod, Arnaud Roth, M.-C. Marti, & John M. Kurtz. (1997). The impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy. Cancer. 79(12). 2329–2335. 45 indexed citations

19.

Allal, Abdelkarim S., Bernadette Mermillod, Arnaud Roth, M.-C. Marti, & John M. Kurtz. (1997). Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. International Journal of Radiation Oncology*Biology*Physics. 39(5). 1099–1105. 46 indexed citations

20.

Roth, Arnaud, R Abele, & Pierre Alberto. (1994). 13-<i>cis</i>-Retinoic Acid Plus Interferon-α: A Phase II Clinical Study in Squamous Cell Carcinoma of the Lung and the Head and Neck. Oncology. 51(1). 84–86. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact